The inhibition of monoamine uptake into rat brain synaptosomess by selected bicyclo-octanes and an analogous bicyclo-octene.
D000475:Alkenes / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D066298:In Vitro Techniques; D009638:Norepinephrine / Q000378:metabolism; D009795:Octanes / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*
D000475:Alkenes; D000928:Antidepressive Agents; D001679:Biogenic Amines; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D009795:Octanes; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine